Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

(HealthDay News) — COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

Researchers are developing an mRNA vaccine to protect against Clostridioides difficile bacteria, known for causing severe ...

Anchor] In the future, it is expected that it will be possible to develop an mRNA vaccine that is sucked into the respiratory ...

GOP presidential candidates, including Ron DeSantis and Donald Trump, have distanced themselves from their 2020 closures and ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

This week, we visit with Katie Lessel Young, a pharmacy resident with Monument Health.